Investors

Newsletter 03
18: announcement from major shareholder
17: Announcement from major shareholder
Note - new short name
16: Shares and Votes
15: Insider's dealings
14: Trading Report
13: Announcement from major shareholder
12: Interim Financial Report for Q2
11: BioPorto’s NGAL patent approved for issue in Europe
10: BioPorto launches Rat NGAL ELISA Kit
09: New diagnostic application of the APC-PCI test
08: Articles of association
07: Interim financial statement, first quarter 2008
Newsletter 02
04: Annual General Meeting
05: Devl. of Annual General Meeting
06: Issue of warrants

13: Announcement from major shareholder

August 29 2008

Announcement no. 13

Announcement from major shareholder

BioPorto A/S has been informed that T. Bernt Nielsen A/S and its associates hold 3,215,927 shares with a nominal value of DKK 3,00 per share in BioPorto A/S, which represents 8,4% of the shares.

Further details:

Christina Tønnesen, Investor Relations

Tel: +45 4529 0000

E-mail: investor@bioporto.com